echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > 2021 EBMT | Chinese Experts International speak again, wonderful inventory, not to be missed!

    2021 EBMT | Chinese Experts International speak again, wonderful inventory, not to be missed!

    • Last Update: 2021-03-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    2021 EBMT is affected by the global new crown epidemic.
    The 47th European Society of Blood and Bone Marrow Transplantation (EBMT) annual meeting in 2021 is scheduled to be held in the form of an online virtual meeting on March 14-17.

    The EBMT Annual Conference is one of the most influential international conferences in the field of blood disease treatment.
    The conference covers major developments related to hematopoietic stem cell transplantation and cell therapy research.

    Currently, China's research on hematopoietic stem cell transplantation and cell therapy is at the world's leading level.

    The "Beijing Plan" for haploid hematopoietic stem cell transplantation has achieved a curative effect that is not inferior to that of allogeneic hematopoietic stem cell transplantation and has been promoted and applied globally.

    The number of clinical studies on chimeric antigen receptor T cell (CAR-T) therapy far exceeds that of the United States.

    With the advancement and innovation of medical technology, China is also playing an increasingly important role in the world's medical field, and more and more Chinese experts are showing their demeanor at international conferences.

    This year, Chinese experts have 2 oral reports and 10 posters shortlisted for the EBMT annual meeting.
    Let’s take a look.post-transplant outcomes of taiwan blood and marrow transplantation registry.
    Speaker: Y.
    -H.
    Wang Unit: National Taiwan University Hospital 10 Abstract Number: P142 Title: Successful treatment of Hepatosplenic T-Cell Lymphoma with intensified myeloablative conditioning regimens followed by unmanipulated haploidentical Hematopoietic stem cell transplantation.
    Speaker: Yanli Zhao Unit: Lu Daopei Hospital 11 Abstract Number: P150 Title: Pegylated G-CSF versus G-CSF following HD-CTX for PBSC mobilization and hematopoietic reconstitution after ASCT in newly diagnosed Multiple Myeloma patients.
    Reporter: Meilan Chen Unit: The First Affiliated Hospital of Sun Yat-sen University 12 Abstract Number: P152 Title: Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed Multiple Myeloma.
    Speaker: Jingli Gu Unit: The First Affiliated Hospital of Sun Yat-sen University Starting today, the Hematology Department of Yimaitong will carry out a series of reports on the 2021 EBMT conference.
    Which field are you more concerned about? Come to the message area and tell us~~~Poke "read the original text" and we will make progress together Wang Unit: National Taiwan University Hospital 10 Abstract Number: P142 Title: Successful treatment of Hepatosplenic T-Cell Lymphoma with intensified myeloablative conditioning regimens followed by unmanipulated haploidentical hematopoietic stem cell transplantation.
    Speaker: Zhao Yanli Unit: Lu Daopei Hospital 11 Abstract Number: P150 Title: Pegylated G-CSF versus G-CSF following HD-CTX for PBSC mobilization and hematopoietic reconstitution after ASCT in newly diagnosed Multiple Myeloma patients.
    Speaker: Meilan Chen Unit: The First Affiliated Hospital of Sun Yat-sen University 12 Abstract Number: P152 Title: Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed Multiple Myeloma.
    Reporter: Jingli Gu Unit: The First Affiliated Hospital of Sun Yat-Sen University Starting today, the Department of Hematopoietic Hematopoietic will carry out a series of reports on the 2021 EBMT conference.
    You are more concerned In which area is progress? Come to the message area and tell us~~~Poke "read the original text" and we will make progress together Wang Unit: National Taiwan University Hospital 10 Abstract Number: P142 Title: Successful treatment of Hepatosplenic T-Cell Lymphoma with intensified myeloablative conditioning regimens followed by unmanipulated haploidentical hematopoietic stem cell transplantation.
    Speaker: Zhao Yanli Unit: Lu Daopei Hospital 11 Abstract Number: P150 Title: Pegylated G-CSF versus G-CSF following HD-CTX for PBSC mobilization and hematopoietic reconstitution after ASCT in newly diagnosed Multiple Myeloma patients.
    Speaker: Meilan Chen Unit: The First Affiliated Hospital of Sun Yat-sen University 12 Abstract Number: P152 Title: Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed Multiple Myeloma.
    Reporter: Jingli Gu Unit: The First Affiliated Hospital of Sun Yat-Sen University Starting today, the Department of Hematopoietic Hematopoietic will carry out a series of reports on the 2021 EBMT conference.
    You are more concerned In which area is progress? Come to the message area and tell us~~~Poke "read the original text" and we will make progress together Speaker: Jingli Gu Unit: From today, the First Affiliated Hospital of Sun Yat-Sen University, the Department of Hematology of Yimaitong will carry out a series of reports on the 2021 EBMT conference.
    Which field are you more concerned about? Come to the message area and tell us~~~Poke "read the original text" and we will make progress together Speaker: Jingli Gu Unit: From today, the First Affiliated Hospital of Sun Yat-Sen University, the Department of Hematology of Yimaitong will carry out a series of reports on the 2021 EBMT conference.
    Which field are you more concerned about? Come to the message area and tell us~~~Poke "read the original text" and we will make progress together Speaker: Jingli Gu Unit: From today, the First Affiliated Hospital of Sun Yat-Sen University, the Department of Hematology of Yimaitong will carry out a series of reports on the 2021 EBMT conference.
    Which field are you more concerned about? Come to the message area and tell us~~~Poke "read the original text" and we will make progress together Speaker: Jingli Gu Unit: From today, the First Affiliated Hospital of Sun Yat-Sen University, the Department of Hematology of Yimaitong will carry out a series of reports on the 2021 EBMT conference.
    Which field are you more concerned about? Come to the message area and tell us~~~Poke "read the original text" and we will make progress together Speaker: Yanli Zhao Unit: Lu Daopei Hospital 11 Abstract Number: P150 Title: Pegylated G-CSF versus G-CSF following HD-CTX for PBSC mobilization and hematopoietic reconstitution after ASCT in newly diagnosed Multiple Myeloma patients.
    Speaker: Meilan Chen Unit: Zhongshan No.
    12 of the First Affiliated Hospital of University Abstract Number: P152 Title: Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed Multiple Myeloma.
    Speaker: Jingli Gu Unit: The First Affiliated Hospital of Sun Yat-Sen University, Medical Pulse The Department of Hematology will conduct a series of reports on the 2021 EBMT conference.
    In which area are you more concerned about the progress? Come to the message area and tell us~~~Poke "read the original text" and we will make progress together Speaker: Zhao Yanli Unit: Lu Daopei Hospital 11 Abstract Number: P150 Title: Pegylated G-CSF versus G-CSF following HD-CTX for PBSC mobilization and hematopoietic reconstitution after ASCT in newly diagnosed Multiple Myeloma patients.
    Speaker: Meilan Chen Unit: Zhongshan No.
    12 of the First Affiliated Hospital of University Abstract Number: P152 Title: Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed Multiple Myeloma.
    Speaker: Jingli Gu Unit: The First Affiliated Hospital of Sun Yat-Sen University, Medical Pulse The Department of Hematology will conduct a series of reports on the 2021 EBMT conference.
    In which area are you more concerned about the progress? Come to the message area and tell us~~~Poke "read the original text" and we will make progress together
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.